() Bovaclox DC LA Dry Cow | Norbrook Laboratories

Bovaclox DC LA Dry Cow Intramammary Suspension

Bovaclox DC LA contains 600 mg cloxacillin (as benzathine salt) and 300 mg ampicillin (as trihydrate) in a long-acting base. For the control of mastitis in dairy cows caused by organisms sensitive to Ampicillin and Cloxacillin during the dry period.

Target Species: Dairy Cattle

  • Active Ingredient

    600 mg cloxacillin (as benzathine salt) and 300 mg ampicillin (as trihydrate) in 5.4g syringe

  • Pharmaceutical Form

    Intramammary preparation

  • Indications

    For the control of mastitis in dairy cows caused by organisms sensitive to Ampicillin and Cloxacillin during the dry period i.e., immediately after the last milking of the lactation. Effective antibiotic levels are maintained in the udder of the dry cow for up to 10 weeks.

  • Dosage

    Prior to infusing Bovaclox DC LA clean and disinfect the teat. Infuse the contents of one syringe per quarter immediately after the final milking of a lactation then teat dip or spray the teat. Rubber gloves should be worn when infusing the suspension.

Prefer to speak directly to a member of our team?

Norbrook Laboratories Australia Pty Ltd.

We are open Mon - Fri 9:00am - 5:00pm

Please note: Product information presented on this website is intended only as a brief summary of Norbrook products for your convenience. Not all products or indications are licensed in every country and may be subject to further local variations. For specific product information you should always consult a healthcare professional from your region or visit the local government agency website for the most up to date information. Please see our terms and conditions for further information.